It was reported on today's wire services that Johnson & Johnson has been sniffing around the arbeitsgemeinschaft osteosynthesfragen in a potential blockbuster deal, that if it was to go down, would be an estimated $20 billion dollar acquisition. If capable of executing a deal of this magnitude, how would this swing the pendulum for Johnson & Johnson when it comes to their trauma and spine business units? For years now various companies have courted Synthes, only to be jilted by the girl they covet. Years ago, Zimmer sniffed the Holy Grail to no avail. Then Stryker had delusions of acquiring Synthes prior to acquiring Howmedica only to be laughed at by this smug starlet. Yes fellow bloggers John Brown and Dave Simpson thought they had an inside track, too stiff to play that riff. Johnson & Johnson attempted to get to the alter, only to be jilted. Unfortunately, they just didn't exude the love and affection that the Wyssmeister was seeking back then. Even though there is some skepticism regarding this deal, one must admit as healthy as Wyss has been, it might be time to sell Synthes and ride off into the sunset so that he could spend whatever time he has on this earth in Big Sky country, riding the range and smelling the sagebrush. So the question must be asked, will this be the blockbuster deal that everyone expected, or, is Wyss up to his old tricks in hope of driving up the price between Johnson & Johnson and whomever else is lurking in the brush. There comes a time when every cowboy must ride off into the sunset, either on his horse or lear jet, and drink the fruits of his labor at the Halter Ranch.
You know what Poco sang many years ago;
"you and I counting desert stars and lovers, one by one
While mandolins and steel guitars help our love song along
who could show you, ever know you, fall into my dream
Turn around and, then you are in cowboy boots and faded jeans
TSB wants to know DEAL or NO DEAL?